Center for Translational and Public Health Genomics
The Center for Translational and Public Health Genomics (CTPHG) was created to bridge the gap between epidemiologic discoveries and their translation into clinical and public health applications to benefit cancer patients, individuals at elevated risk for cancer, and the general population. Leveraging the large patient population and healthy controls with comprehensive data and biospecimens and the rapid development of new high-throughput biomedical technologies that generate genomic information at an unprecedented pace, the Center contributes to the institutional commitment of personalized medicine by providing expertise in translational genomics for cancer risk, prevention interventions, progression from pre-malignancy to cancer, pharmacogenomics to predict therapeutic response, and survivorship and quality of life. More information
Mentored Junior Faculty Fellowship
Applications are being accepted for the Duncan Family Institute Mentored Junior Faculty Fellowship in Cancer Prevention Research.
Cancer Prevention and Population Sciences Faculty in the News
- Feds will regulate E-cigarettes, cigars, and other nicotine alternatives Ernest Hawk, M.D., M.P.H.
- The "Fat Woman's" cancer Karen Basen-Engquist, Ph.D., M.P.H.
- CVS pharmacy plans to pull cigarettes off shelves Alex Prokhorov, M.D., Ph.D.
- Exercise helps women tolerate breast cancer drugs, study finds Powel Brown, M.D., Ph.D.